Organon And Philips Team Up To Study Drug Effects At The Molecular Level
N.V. Organon, the human health care business unit of Akzo Nobel, and Royal Philips Electronics announced today that they will join forces in the development of new drugs and therapies for mental disorders and cancer. [click link for full article]
More: continued here
Filed under: Cancer on May 28th, 2007